[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.54.109. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Correspondence
October 1999

Therapy-Resistant Erythrodermia-Related Pruritus: Effective Treatment With Ketamine Hydrochloride

Author Affiliations

Not Available

Arch Dermatol. 1999;135(10):1274-1275. doi:10-1001/pubs.Arch Dermatol.-ISSN-0003-987x-135-10-dlt1099

Erythrodermia is frequently accompanied by severe itching that is often resistant to treatment. In two cases, we found that low-dose treatment with ketamine hydrochloride was followed by a notable improvement of the pruritus symptoms.

A 58-year-old patient presented with chronic and persistent pruritus associated with idiopathic erythrodermia. Combination therapy with methotrexate and prednisolone was given for 4 months. Under this treatment, the patient developed herpes zoster infection in the left lateral segment (cervical vertebrae, C3 through C4), with subsequent extreme post-zoster neuralgia. Low-dosage intravenous ketamine hydrochloride therapy (single dose, 7.5 mg/d; weight, 58 kg) was therefore initiated. There was a clear reduction in pain, and the continuous severe itching also decreased. The patient had poor compliance. Consequently, the treatment could not be continued as oral therapy on an outpatient basis and it was also impossible to quantify the pruritus on a visual scale.

First Page Preview View Large
First page PDF preview
First page PDF preview
×